ATE170631T1 - Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase - Google Patents

Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase

Info

Publication number
ATE170631T1
ATE170631T1 AT94909759T AT94909759T ATE170631T1 AT E170631 T1 ATE170631 T1 AT E170631T1 AT 94909759 T AT94909759 T AT 94909759T AT 94909759 T AT94909759 T AT 94909759T AT E170631 T1 ATE170631 T1 AT E170631T1
Authority
AT
Austria
Prior art keywords
alkaline phosphatase
composition
effects
endogene
reducing
Prior art date
Application number
AT94909759T
Other languages
English (en)
Inventor
Pratap Singh
Randy W Johnson
Original Assignee
Dade Behring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Inc filed Critical Dade Behring Inc
Application granted granted Critical
Publication of ATE170631T1 publication Critical patent/ATE170631T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
AT94909759T 1993-02-17 1994-02-14 Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase ATE170631T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1866193A 1993-02-17 1993-02-17

Publications (1)

Publication Number Publication Date
ATE170631T1 true ATE170631T1 (de) 1998-09-15

Family

ID=21789125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909759T ATE170631T1 (de) 1993-02-17 1994-02-14 Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase

Country Status (10)

Country Link
US (1) US5948630A (de)
EP (1) EP0636247B1 (de)
JP (1) JP3350730B2 (de)
AT (1) ATE170631T1 (de)
AU (1) AU6247494A (de)
CA (1) CA2118231A1 (de)
DE (1) DE69412940T2 (de)
DK (1) DK0636247T3 (de)
ES (1) ES2123774T3 (de)
WO (1) WO1994019691A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524170A (en) * 2000-09-07 2004-08-27 Tokyo Gas Co Ltd Preparations for diagnosis of pancreatic exocrine function
US7888372B2 (en) * 2001-03-23 2011-02-15 National Institutes Of Health (Nih) Compositions and methods for modulating bone mineral deposition
JP4567326B2 (ja) * 2003-12-24 2010-10-20 三菱化学メディエンス株式会社 全血を用いる測定法
US7749722B2 (en) 2005-12-15 2010-07-06 Mitsubishi Kagaku Istron, Inc. Measuring method using whole blood
JP5137620B2 (ja) * 2007-04-03 2013-02-06 シスメックス株式会社 アルカリホスファターゼ標識検出用試薬キット、免疫測定用試薬キット及び免疫測定方法
EP1978363B1 (de) 2007-04-03 2010-02-24 Sysmex Corporation Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren
US20090104634A1 (en) * 2007-10-21 2009-04-23 Abbott Laboratories One-step immunoassays exhibiting increased sensitivity and specificity
CN110194774B (zh) * 2019-06-05 2021-12-28 苏州百灵威超精细材料有限公司 5,6-二氢-6-(2-萘基)咪唑并[2,1-b]噻唑草酸盐的制备方法
CN111289456B (zh) * 2020-03-31 2023-04-07 西安交通大学第二附属医院 一种检测粪便及肠道组织中肠碱性磷酸酶iap的方法
JP2022045047A (ja) * 2020-09-08 2022-03-18 デンカ株式会社 偽陰性の抑制により特異性を改善した検査試薬
CN113267390B (zh) * 2021-05-11 2023-05-05 北京丹大生物技术有限公司 一种用于滤纸干血片的检测标志物洗脱液及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325356A (en) * 1965-08-20 1967-06-13 Merck & Co Inc Compositions and method for treating helminthiasis
US4150141A (en) * 1977-06-28 1979-04-17 Johnson & Johnson Treatment for scabies
US4220153A (en) * 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
US4517288A (en) * 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4543358A (en) * 1982-12-13 1985-09-24 American Cyanamid Company Anthelmintic gel composition and a method for their preparation at ambient temperatures
US4781920A (en) * 1984-11-13 1988-11-01 American Cyanamid Company Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
US5135847A (en) * 1988-11-18 1992-08-04 Becton, Dickinson And Company Substrate composition for alkaline phosphatase and method for assay using same
US5124245A (en) * 1989-02-09 1992-06-23 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen
US5279935A (en) * 1990-03-01 1994-01-18 Becton, Dickinson And Company Method of immunossay including deactivation of endogenous alkaline phosphatase
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay

Also Published As

Publication number Publication date
DE69412940D1 (de) 1998-10-08
DK0636247T3 (da) 1999-05-31
DE69412940T2 (de) 1999-05-12
ES2123774T3 (es) 1999-01-16
CA2118231A1 (en) 1994-09-01
JP3350730B2 (ja) 2002-11-25
EP0636247B1 (de) 1998-09-02
WO1994019691A1 (en) 1994-09-01
EP0636247A1 (de) 1995-02-01
US5948630A (en) 1999-09-07
JPH07506437A (ja) 1995-07-13
AU6247494A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
DE69730388D1 (de) Metall-Keramik-Substrate von hoher Zuverlässigkeit für Halbleiter
DE69528528T2 (de) Thrombin-inhibitoren
NO962269D0 (no) Enzyminhibitorer
ATE214928T1 (de) Thrombininhibitoren
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
DE69009088T2 (de) Verbindungsverfahren für Schaltungen und Klebefilm dafür.
DE69008423D1 (de) Dynamische Fixierung von Schweinsaortaklappen.
DE69308161T2 (de) Beschichtungszusammensetzungen für nichtklebende oberflächen
ATE170631T1 (de) Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
ATE332919T1 (de) Inhibitoren von phosphoserin- und phosphothreoninspezifischen isomerasen
DE69332770D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfamidsäuren verwendbar als retrovirale Proteasehemmer
PT766557E (pt) Composicoes de aplicacao topica compreendendo n-acetil-cisteina
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
NO904463D0 (no) Korrosjonsinhibitor.
NO982715L (no) Endotel celle-proliferasjonsinhibitor og fremgangsmate for anvendelse
BR9711367A (pt) Elemento estrutural eletrocer mico e processo para sua fabrica-Æo
DE69325323T2 (de) Prüfeinrichtung, insbesondere zur Oberflächenkontrolle von Zigaretten
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
TR199701013T1 (xx) Nitrik oksit synthas'�n�n inhibit�rleri olarak mercapto ve seleno t�revleri.
DE69431549D1 (de) Verfahren zur Einebnung von Halbleiterbauflächen und durch dieses Verfahren hergestellte Bauelemente
DE69133166T2 (de) Inhibitoren von katalytischen antikörpern
FR2569569B1 (fr) Exerciseur destine notamment au travail du grand ecart.
FI965289A (fi) DP-1:n ja muiden DP-proteiinien estäjien määritys
DE3577456D1 (de) Fluessige zusammensetzung zur behandlung von metalloberflaechen.
ATE235969T1 (de) Verfahren zur beschichtung von siliconelastomeren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee